HMGA2 and pancreatic ductal adenocarcinoma: For clear cell renal cell carcinoma, head and neck cancer, hepatocellular carcinoma, and pancreatic ductal adenocarcinoma, patients with high HMGA2 expression have shorter overall survivals.